Skip main navigation

Main contents starts here

Press Releases

January 13, 2009

Takeda Pharmaceutical Company Limited

Appointment of New CEO of Takeda Pharmaceuticals Asia Private Limited

Osaka, Japan, January 13, 2009 --- Takeda Pharmaceutical Company Limited (“Takeda”) today announced the appointment of Mr. Stefan Ziegler as CEO of Takeda Pharmaceuticals Asia Private Limited (“TPAsia”), its wholly owned subsidiary for oversight of overall Asian sales and marketing. Mr. Ziegler received a bachelor’s degree in Business administration with major in Finance and Marketing at University of Zurich in Switzerland and worked at Novartis from 1990 to 2008.

“We are excited to welcome Mr. Ziegler to Takeda,” said Yasuchika Hasegawa, President of Takeda. “With many years of experience in the Asian pharmaceutical industry as an executive, we believe Mr. Ziegler will bring a tremendous amount of perspective to Takeda in a pivotal position such as CEO of TPAsia.”

“I am very pleased to join Takeda, a growth oriented multinational pharmaceutical company and to accept this exciting challenge to lead TPAsia, which is a core organization for Takeda’s operations in Asia,” said Stefan Ziegler. “Through new product introductions, innovative services and territorial expansion, I am determined to further enhance Takeda’s business foundation in Asia, a large geographical area with great business potential. It is my intension to do this in the spirit of Takeda’s business philosophy and by working closely with Takeda Head Quarter.”

TPAsia will supervise the overall business activities of Takeda’s sales and marketing subsidiaries in five Asian locations (Taiwan, Thailand, the Philippines, Indonesia and China) [*], and will promote the optimal strategies centered on sales and marketing for the Asian region from medium and long-term perspectives. Takeda is aiming for the expansion of market share for each of the current Asian sales and marketing subsidiaries and for further entry into new markets through establishment of TPAsia, thereby realizing improved presence for Takeda in the Asian region.

[*] Takeda Pharmaceuticals Taiwan, Ltd., Takeda (Thailand), Ltd., Takeda Pharmaceuticals (Philippines), Inc., P.T. Takeda Indonesia, Tianjin Takeda Pharmaceuticals Co., Ltd.

Company Outline

Company name : Takeda Pharmaceuticals Asia Private Limited
Location : Singapore
Capital : 6.7 million Singapore dollars
Establishment : September 2008

# # #

Skip sub navigation

Newsroom

Press Releases' Search

Page Top